Literature DB >> 23093676

HIV-1 Nef interferes with T-lymphocyte circulation through confined environments in vivo.

Bettina Stolp1, Andrea Imle, Fernanda Matos Coelho, Miroslav Hons, Roser Gorina, Ruth Lyck, Jens V Stein, Oliver T Fackler.   

Abstract

HIV-1 negative factor (Nef) elevates virus replication and contributes to immune evasion in vivo. As one of its established in vitro activities, Nef interferes with T-lymphocyte chemotaxis by reducing host cell actin dynamics. To explore Nef's influence on in vivo recirculation of T lymphocytes, we assessed lymph-node homing of Nef-expressing primary murine lymphocytes and found a drastic impairment in homing to peripheral lymph nodes. Intravital imaging and 3D immunofluorescence reconstruction of lymph nodes revealed that Nef potently impaired T-lymphocyte extravasation through high endothelial venules and reduced subsequent parenchymal motility. Ex vivo analyses of transendothelial migration revealed that Nef disrupted T-lymphocyte polarization and interfered with diapedesis and migration in the narrow subendothelial space. Consistently, Nef specifically affected T-lymphocyte motility modes used in dense environments that pose high physical barriers to migration. Mechanistically, inhibition of lymph node homing, subendothelial migration and cell polarization, but not diapedesis, depended on Nef's ability to inhibit host cell actin remodeling. Nef-mediated interference with in vivo recirculation of T lymphocytes may compromise T-cell help and thus represents an important mechanism for its function as a HIV pathogenicity factor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093676      PMCID: PMC3494961          DOI: 10.1073/pnas.1204322109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

2.  HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling.

Authors:  Xiaoyu Pan; Jochen M Rudolph; Libin Abraham; Anja Habermann; Claudia Haller; Jacomine Krijnse-Locker; Oliver T Fackler
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

Review 3.  Mechanisms of leukocyte transendothelial migration.

Authors:  William A Muller
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse.

Authors:  Claudia Haller; Nadine Tibroni; Jochen M Rudolph; Robert Grosse; Oliver T Fackler
Journal:  Eur J Cell Biol       Date:  2010-11-01       Impact factor: 4.492

5.  In vivo analysis of uropod function during physiological T cell trafficking.

Authors:  Silvia F Soriano; Miroslav Hons; Kathrin Schumann; Varsha Kumar; Timo J Dennier; Ruth Lyck; Michael Sixt; Jens V Stein
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

Review 6.  Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins.

Authors:  Nadine Laguette; Christelle Brégnard; Serge Benichou; Stéphane Basmaciogullari
Journal:  Mol Aspects Med       Date:  2010-06-04

7.  HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice.

Authors:  Hideki Fujii; Manabu Ato; Yoshimasa Takahashi; Kaori Otake; Shu-Ichi Hashimoto; Tomohiro Kaji; Yasuko Tsunetsugu-Yokota; Mikako Fujita; Akio Adachi; Toshinori Nakayama; Masaru Taniguchi; Shigeo Koyasu; Toshitada Takemori
Journal:  Int Immunol       Date:  2011-06-03       Impact factor: 4.823

Review 8.  Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers.

Authors:  Ronen Alon; Ziv Shulman
Journal:  Exp Cell Res       Date:  2011-03-10       Impact factor: 3.905

9.  Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: evidence supporting the reticular network as a pathway for lymphocyte migration.

Authors:  Gregg P Sobocinski; Katherine Toy; Walter F Bobrowski; Stephen Shaw; Arthur O Anderson; Eric P Kaldjian
Journal:  BMC Immunol       Date:  2010-08-17       Impact factor: 3.615

10.  Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation.

Authors:  Joya Mukerji; Kevin C Olivieri; Vikas Misra; Kristin A Agopian; Dana Gabuzda
Journal:  Retrovirology       Date:  2012-06-22       Impact factor: 4.602

View more
  36 in total

1.  Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening.

Authors:  Matthias Schröder; Simone Loos; Svenja Kerstin Naumann; Christopher Bachran; Marit Krötschel; Viktor Umansky; Laura Helming; Lee Kim Swee
Journal:  Oncoimmunology       Date:  2016-11-29       Impact factor: 8.110

2.  HIV-1 Nef CAWLEAQ motif: a regulator of monocytes invasion through ENO1 modulation.

Authors:  Reshu Saxena; Umesh Kumar Vekariya; Pradeep Kumar; Amit Kumar Tripathi; Jimut Kanti Ghosh; Raj Kamal Tripathi
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

3.  Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients.

Authors:  Ting Wang; Linden A Green; Samir K Gupta; Tohti Amet; Daniel J Byrd; Qigui Yu; Homer L Twigg; Matthias Clauss
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-04       Impact factor: 2.205

Review 4.  Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Authors:  Oliver T Fackler; Thomas T Murooka; Andrea Imle; Thorsten R Mempel
Journal:  Nat Rev Microbiol       Date:  2014-08       Impact factor: 60.633

5.  The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  Heterologous Src homology 4 domains support membrane anchoring and biological activity of HIV-1 Nef.

Authors:  Miriam M Geist; Xiaoyu Pan; Silke Bender; Ralf Bartenschlager; Walter Nickel; Oliver T Fackler
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

Review 7.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

8.  HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Authors:  Lia Vassena; Erica Giuliani; Herwig Koppensteiner; Sebastian Bolduan; Michael Schindler; Margherita Doria
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.

Authors:  Birthe Trautz; Virginia Pierini; Rebecka Wombacher; Bettina Stolp; Amanda J Chase; Massimo Pizzato; Oliver T Fackler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization.

Authors:  Valentina Cecchinato; Enos Bernasconi; Roberto F Speck; Michele Proietti; Ulrike Sauermann; Gianluca D'Agostino; Gabriela Danelon; Tanja Rezzonico Jost; Fabio Grassi; Lorenzo Raeli; Franziska Schöni-Affolter; Christiane Stahl-Hennig; Mariagrazia Uguccioni
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.